Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma (UC). Hahn, N. M., Powles, T., Massard, C., Arkenau, H., Friedlander, T. W., Holmes, C. J., Lee, J., Ong, M., Sridhar, S. S., Vogelzang, N. J., Fishman, M. N., Zhang, J., Srinivas, S., Parikh, J., Antal, J., Jin, X., Ben, Y., Gupta, A., O'Donnell, P. H. AMER SOC CLINICAL ONCOLOGY. 2017

View details for DOI 10.1200/JCO.2017.35.15_suppl.4525

View details for Web of Science ID 000411931702025